The Biden administration dropped a new proposal Friday designed to fix the controversial dispute resolution process that’s part of the federal surprise billing ban. Since
WASHINGTON — The Senate Finance Committee plans to vote Nov. 8 on legislation that includes substance abuse and mental health policies, reforms to drug middlemen’s
As the psychedelic movement transforms and develops into a new entity, there is bound to be internal conflict and opposition. The fight to include indigenous
A rapid, accurate way of testing for COVID-19 infection would be a big step in overcoming the virus’ hold over our society.
Announcing a new article publication for Zoonoses journal. A multi-country cholera outbreak has occurred in several developing countries in Africa, Asia and Oceania since mid-2021.
Childhood trauma is a key risk factor for future substance use disorder, overdose, and suicide. This is particularly problematic in rural areas where children experience
Researchers from the University of Bergen (UiB) have uncovered that proteins use a common chemical label as a shield to protect them from degradation, which
WASHINGTON — The Biden administration is slowly shifting millions of Covid-19 treatments to private insurers and drugmakers, starting next week. The transition to commercial payers
Despite rising global mobility, the state of migrant and refugee health data in European health systems is a concern, a new study shows.
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The U.S. International Trade Commission